Reprieve Cardiovascular

Developer of decongestion management solution for acute decompensated heart failure patients

placeMilford, Massachusetts, United States calendar_todayFounded 2018 groups16 employees language reprievecardio.com

Innovation

14 patent families (9 granted) — focus: Human necessities, Physics & computing; filing pace accelerating. Cited 2,892 times.

YearFilings
20213
20226
20234
20248
20258
20262

Social engagement

Social engagement: 3.1K social following, 5 posts in the last 12 months — below the industry typical range.

Investor mix

10 investors on record; lead investors include Lightstone Ventures, Sante, Deerfield, Genesis Capital.

Investor typeCountShare
Venture capital550%
Private equity110%
Bank & private debt220%
Other / undisclosed220%

Recent activity

26 Jun 2026
Event
AAHFN2026
7 May 2026
Milestone
regulatory
2 Mar 2026
Event
Last Breaking Clinical Science session at THET2026
Coming soon